Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Multiple Primary

Explore clinical trials studying Neoplasms, Multiple Primary. Study availability and eligibility vary by location and protocol.

286 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Multiple Primary trial results

Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Completed

Protein-Prebiotic Wellbeing Study

NCT05303753

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive Health, Endocrine Gland Neoplasms, +9 more
Locations
  • Arizona State University Phoenix, Arizona, United States
View Trial Details
Completed

HPV Vaccine Intervention for Young Sexual Minority Men

NCT04032106

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +8 more
Locations
  • University of Minnesota Minneapolis, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception

NCT03452111

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +10 more
Locations
  • UC Davis Health Sacramento, California, United States
  • The Lunquist Institute at Harbor-UCLA Medical Center Torrance, California, United States
  • Comprehensive Women's Health Center Denver, Colorado, United States
  • University of Kansas Kansas City, Kansas, United States
View all 17 locations
View Trial Details
Completed

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.

NCT02437318

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
View all 197 locations
View Trial Details

Related conditions